![N-[3-Methyl-4-(2, 2, 2-trifluoroethoxy)-2-pyridinyl]methyl Lansoprazole-d4 13790 NAD+ precursor NMN treatment inhibited](https://cdn.shopify.com/s/files/1/0389/1897/9723/products/M23680_1635915649.gif?v=1635915651)
Pay in 4 interest-free payments of $25.00 Learn more
Ships within 48 hours · Estimated delivery Aug 5 - Aug 10
NAD+ precursor NMN treatment inhibited CD8+ T cells activation and function
component of a number of hair and skin conditioners
Lipid lowering in healthy volunteers treated with multiple doses of MGL-3196
50)51)23(45)30(58-19)41-16-39-22-26(32)37-15-38-28(22)41
48 hours) results in a dose-dependent inhibition of viable cell count and proliferation in both T98G and U87MG glioma and BTSCs
N-[3-Methyl-4-(2, 2, 2-trifluoroethoxy)-2-pyridinyl]methyl Lansoprazole-d4 13790 NAD+ precursor NMN treatment inhibitedProduct information CAS Number: 1794756 36 7 Molecular Weight: 576. 55 Formula: C25H22F6N4O3S Chemical Name: 2 {[3 methyl 4 (2,2,2 trifluoroethoxy)pyridin 2 yl]methanesulfinyl} 1 {[3 methyl 4 (2,2,2 trifluoroethoxy)pyridin 2 yl]methyl}(H) 1H 1,3 benzodiazole Smiles: [2H]C1C2=C(N=C(N2CC2=NC=CC(OCC(F)(F)F)=C2C)S(=O)CC2=NC=CC(OCC(F)(F)F)=C2C)C([2H])=C([2H])C=1[2H] InChiKey: GUWVDDXKNHBOLX LNFUJOGGSA N InChi: InChI=1S C25H22F6N4O3S c1 15 18(32 9 7